Physician profile
Kenneth E Farmer
NPI 1962458380
$3,036.20
in general payments reported to CMS, 2019-2025
29 companies · $448 in 2025
The $448 reported for 2025 was more than what 76% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $429 · 2021: $580 · 2022: $410 · 2023: $300 · 2024: $375 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $798.96 | 2019-2025 | |
| Astellas Pharma US INC | $453.69 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $255.16 | 2019-2025 | |
| Hologic Sales and Service, LLC | $240.43 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Coolseal Generator |
| Sumitomo Pharma America, INC. | $218.08 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $164.91 | 2021-2023 | Slynd |
| Caldera Medical, INC | $129.24 | 2020 | |
| Amgen INC. | $71.81 | 2019-2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $69.88 | 2019-2022 | |
| Sage Therapeutics, LLC | $56.90 | 2024-2025 | Zurzuvae |
| Urovant Sciences INC | $56.37 | 2022 | |
| Mayne Pharma Commercial LLC | $55.05 | 2022-2023 | |
| Scynexis, INC. | $54.90 | 2022 | |
| Myovant Sciences INC. | $48.87 | 2021-2022 | |
| Therapeuticsmd, INC. | $42.17 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $42.07 | 2020-2022 | |
| Duchesnay USA Incorporated | $34.64 | 2019 | |
| Organon LLC | $32.19 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $28.98 | 2019-2024 | Summit Doppler |
| Solventum Corporation | $24.51 | 2025 | Prevena |
| Conmed Corporation | $22.15 | 2023 | Airseal |
| Davol INC. | $21.90 | 2020 | |
| Radius Health, INC. | $20.24 | 2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.18 | 2022 | |
| Millicent US INC | $16.82 | 2024 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $15.98 | 2019 | |
| Shield Therapeutics INC | $15.58 | 2024 | |
| Lupin INC. | $13.78 | 2019 | |
| Medtronic, INC. | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.